Australia Works On Improving Use Of Boxed Warnings For Prescription Drugs
Executive Summary
The Therapeutic Goods Administration has also suggested possible options to ensure boxed warnings are included in all promotional materials issued by sponsors.
You may also be interested in...
Industry Raises Concerns Over Australian ‘Boxed Warning’ Proposals
Stakeholders have generally welcomed draft Australian guidance on boxed warnings but concerns have been raised about the impact of using them too frequently and the kind and level of evidence that will be required.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.